IP Library Granted Patent US 7,230,147
Granted Patent B2
US 7,230,147 · App. 10/866,586 · Granted Jun 12, 2007

Process for functionalizing a double bond

Assignee: Shasun Pharma Solutions Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,230,147
App. No.
10/866,586
Granted
Jun 12, 2007
Kind
B2
Abstract

The invention concerns a method for functionalizing a double bond and, more particularly, a double bond bearing a metalloid atom. Said functionalization is produced by the action of perhalogenated sulphonyl chloride on the carbon bearing sulphur in the presence of a free radical initiator, preferably by homolytic cleavage. The invention is useful in organic synthesis.

Claims (20)

1. A process for functionalizing a double bond corresponding to the following formula I:

wherein:

R 1 , R 2 and R 3 , are hydrogen atoms attached to said double bond via an sp 3 carbon, wherein:

Z is CH 2 —O—R 4 , where

R 4 is a hydrocarbyl or silyl group,

said process comprising the step reacting without polymerizing said double bond with a sulfonyl chloride compound perhalogenated on a sulfur-bearing carbon of the sulfonyl function, in the presence of a free-radical initiator, wherein the free-radical initiator is an initiator by homolytic cleavage.

2. The process according to claim 1 , wherein R 4 is an electron-withdrawing group.

3. The process according to claim 1 , wherein the perhalogenated sulfonyl chloride has the formula R f —SO 2 —Cl, wherein R f has the formula

EWG—(CX 2 ) p —, wherein:

X groups, which are similar or different, represent a chlorine atom, a fluorine atom or a group of formula C n F 2n+1 wherein n is an integer of not more than 5, with the condition that at least one of the X groups is fluorine,

p is integer of not more than 2,

EWG is an electron-withdrawing group, optionally comprising functions, said functions being inert under the reaction conditions, and

the total number of carbon atoms in R f is of between 1 and 15.

4. The process according to claim 3 , wherein:

X groups, which are similar or different, represent a chlorine atom, a fluorine atom or a group of formula C n F 2n+1 wherein n is an integer of not more than 2, with the condition that at least one of the X groups is fluorine, EWG is an electron-withdrawing group, comprising inert functions under the reaction conditions, said functions being a fluorine atom or a perfluoro residue of formula C n F 2n+1 , with n being an integer of not more than 8,

the total number of carbon in R f is of between 1 and 10.

5. The process according to claim 3 , wherein R f contains not more than 6 carbon atoms.

6. The process according to claim 5 , wherein R f contains not more than 3 carbon atoms.

7. The process according to claim 1 , wherein R 4 is an acyl group comprising not more than 15 carbon atoms.

8. The process according to claim 7 , wherein the acyl group comprises not more than 10 carbon atoms.

Assignments (1)
CHANGE OF NAME Recorded Oct 27, 2006
From: RHODIA PHARMA SOLUTIONS, INC.
To: SHASUN PHARMA SOLUTIONS, INC.
Reel/Frame 018536/0460 →
Priority Claims (1)
FR 00 01744 · Feb 11, 2000 · national
Continuity (2)
Continuation 1020307500 · Aug 6, 2002
Related Publication 20040225160A1 · Nov 11, 2004